Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- PMID: 35636906
- PMCID: PMC8843334
- DOI: 10.1016/j.idc.2022.02.004
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Abstract
Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or long coronavirus disease (COVID) is an emerging syndrome characterized by multiple persisting or newly emergent symptoms following the acute phase of SARS-CoV-2 infection. For affected patients, these prolonged symptoms can have a relapsing and remitting course and may be associated with disability and frequent health care utilization. Although many symptom-driven treatments are available, management remains challenging and often requires a multidisciplinary approach. This article summarizes the emerging consensus on definitions, epidemiology, and pathophysiology of long COVID and discusses what is understood about prevention, evaluation, and treatment of this syndrome.
Keywords: COVID-19; Long COVID; Long-haul COVID; Postacute COVID-19; Postacute sequelae of SARS-CoV-2 infection (PASC); SARS-CoV-2.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure T.H. Evering, author, is a consultant for Tonix Pharmaceuticals. Aluko A. Hope is funded by the NIH (K01 HL 140279). I am waiting to hear from Teresa regarding her NIH funding sources.
References
-
- Datta S.D., Talwar A., Lee J.T. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. JAMA. 2020;324(22):2251–2252. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous